Paul Scott‐Stevens

883 citations

14 papers · 446 indexed · h-index 11

Co-authors: Gillian F. Watt Lu Gaohua John Atack Bindi Sohal Philip Worboys Jill Richardson Odile Dewit Zahid Ali
Topics: Neuroscience and Neuropharmacology Research (5 papers)Protein Degradation and Inhibitors (5 papers)Ubiquitin and proteasome pathways (4 papers)
Cited by: Physiology Biological Psychiatry Molecular Biology
Journals: Angewandte Chemie International Edition PLoS ONE Journal of Medicinal Chemistry
Partner nations: United Kingdom United States China

In The Last Decade

Paul Scott‐Stevens

14 papers receiving 432 citations

Peers

Countries citing papers authored by Paul Scott‐Stevens

Since Specialization

Citations

This map shows the geographic impact of Paul Scott‐Stevens's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul Scott‐Stevens with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul Scott‐Stevens more than expected).

Fields of papers citing papers by Paul Scott‐Stevens

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul Scott‐Stevens. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul Scott‐Stevens. The network helps show where Paul Scott‐Stevens may publish in the future.

Co-authorship network of co-authors of Paul Scott‐Stevens

This figure shows the co-authorship network connecting the top 25 collaborators of Paul Scott‐Stevens. A scholar is included among the top collaborators of Paul Scott‐Stevens based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul Scott‐Stevens. Paul Scott‐Stevens is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

#	Work	Indexed citations
1	Industry Perspective on the Pharmacokinetic and Absorption, Distribution, Metabolism, and Excretion Characterization of Heterobifunctional Protein Degraders 2023 ·Drug Metabolism and Disposition ·(unknown),(unknown),Sara C. Humphreys,David O. Nettleton,Colin Phipps,Andy Pike,Caroline Rynn,Paul Scott‐Stevens,Donglu Zhang,Michael Zientek	29
2	Discovery and Characterisation of Highly Cooperative FAK‐Degrading PROTACs 2021 ·Angewandte Chemie International Edition ·Robert P. Law,João Nunes,Chun‐wa Chung,Marcus Bantscheff,(unknown),Han Dai,John P. Evans,(unknown),(unknown),Antonia J. Lewis,Marcel Muelbaier,Paul Scott‐Stevens,Peter Stacey,(unknown),Gillian F. Watt,Nico Zinn,Markus A. Queisser,John D. Harling,Andrew B. Benowitz	85
3	Discovery and Characterisation of Highly Cooperative FAK‐Degrading PROTACs 2021 ·Angewandte Chemie ·Robert P. Law,João Nunes,Chun‐wa Chung,Marcus Bantscheff,(unknown),Han Dai,John P. Evans,(unknown),(unknown),Antonia J. Lewis,Marcel Muelbaier,Paul Scott‐Stevens,Peter Stacey,(unknown),Gillian F. Watt,Nico Zinn,Markus A. Queisser,John D. Harling,Andrew B. Benowitz	4
4	Optimization of a Series of RIPK2 PROTACs 2021 ·Journal of Medicinal Chemistry ·Afjal H. Miah,Ian E. Smith,M.D. Rackham,(unknown),Aditya R. Thawani,Rakesh Nagilla,Pamela A. Haile,Bartholomew J. Votta,Laurie Gordon,Gillian F. Watt,Jane Denyer,(unknown),(unknown),(unknown),(unknown),Ian Churcher,Paul Scott‐Stevens,John D. Harling	49
5	Targeted protein degradation in vivo with Proteolysis Targeting Chimeras: Current status and future considerations 2019 ·Drug Discovery Today Technologies ·Gillian F. Watt,Paul Scott‐Stevens,Lu Gaohua	49
6	Rapid Bioavailability and Disposition protocol: A novel higher throughput approach to assess pharmacokinetics and steady-state brain distribution with reduced animal usage 2018 ·European Journal of Pharmaceutical Sciences ·(unknown),(unknown),Paul Scott‐Stevens,Yan Chen,(unknown),Jianfei Wang,Scott Summerfield,Houfu Liu,Jasminder Sahi	1
7	First Administration of the Fc-Attenuated Anti-β Amyloid Antibody GSK933776 to Patients with Mild Alzheimer’s Disease: A Randomized, Placebo-Controlled Study 2015 ·PLoS ONE ·Niels Andreasen,Monica Simeoni,(unknown),(unknown),Tormod Fladby,Amy Loercher,Gerard J. Byrne,(unknown),Paul Scott‐Stevens,Anders Wallin,(unknown),Lena Bronge,Henrik Zetterberg,Agneta Nordberg,Astrid Yeo,Shahid A. Khan,Jan Hilpert,Prafull Mistry	27
8	Pharmacokinetic and pharmacodynamic profiling of a P2X7 receptor allosteric modulator GSK1482160 in healthy human subjects 2012 ·British Journal of Clinical Pharmacology ·Zahid Ali,Bart Laurijssens,Thor Ostenfeld,Simon McHugh,(unknown),Paul Scott‐Stevens,Louise K. Hosking,Odile Dewit,Jill Richardson,Chao Chen	86
9	Benzodiazepine Binding Site Occupancy by the Novel GABAA Receptor Subtype-Selective Drug 7-(1,1-Dimethylethyl)-6-(2-ethyl-2H-1,2,4-triazol-3-ylmethoxy)-3-(2-fluorophenyl)-1,2,4-triazolo[4,3-b]pyridazine (TPA023) in Rats, Primates, and Humans 2009 ·Journal of Pharmacology and Experimental Therapeutics ·John Atack,Dean F. Wong,Tim D. Fryer,Christine Ryan,Sandra Sanabria,Yun Zhou,Robert F. Dannals,(unknown),Raymond E. Gibson,H. Donald Burns,José M. Vega,(unknown),Paul Scott‐Stevens,John S. Beech,Jean‐Claude Baron,Bindi Sohal,Michael Schrag,Franklin I. Aigbirhio,Ruth M. McKernan,Richard Hargreaves	27
10	Contribution of specific binding to the central benzodiazepine site to the brain concentrations of two novel benzodiazepine site ligands 2007 ·Biopharmaceutics & Drug Disposition ·Andrew Pike,Susan M. Cook,Alan P. Watt,Paul Scott‐Stevens,Thomas W. Rosahl,Ruth M. McKernan,(unknown),(unknown),Christopher R. Moyes,Bindi Sohal,John Atack	2
11	Comparison of Lorazepam [7-Chloro-5-(2-chlorophenyl)-1,3-dihydro-3-hydroxy-2 H-1,4-benzodiazepin-2-one] Occupancy of Rat Brain γ-Aminobutyric AcidA Receptors Measured Using in Vivo [3H]Flumazenil (8-Fluoro 5,6-dihydro-5-methyl-6-oxo-4 H-imidazo[1,5-a][1,4]benzodiazepine-3-carboxylic Acid Ethyl Ester) Binding and [11C]Flumazenil Micro-Positron Emission Tomography 2006 ·Journal of Pharmacology and Experimental Therapeutics ·John Atack,Paul Scott‐Stevens,John S. Beech,Tim D. Fryer,(unknown),Marcel Cleij,Jean‐Claude Baron,John C. Clark,Richard Hargreaves,Franklin I. Aigbirhio	14
12	Aldehyde oxidase and its contribution to the metabolism of a structurally novel, functionally selective GABA_Aα5-subtype inverse agonist 2006 ·Xenobiotica ·Desmond O’Connor,Philip Jones,Mark S. Chambers,(unknown),(unknown),(unknown),Paul Scott‐Stevens,Angus M. MacLeod,Matthew P. Braun,(unknown)	11
13	Rodent pharmacokinetics and receptor occupancy of the GABA_A receptor subtype selective benzodiazepine site ligand L‐838417 2004 ·Biopharmaceutics & Drug Disposition ·Paul Scott‐Stevens,John Atack,Bindi Sohal,Philip Worboys	44
14	An Evaluation of a Low-Density DNA Microarray Using Cytochrome P450 Inducers 2003 ·Chemical Research in Toxicology ·Georgina Meneses‐Lorente,Françoise de Longueville,(unknown),Timothy P. Bonnert,Andrew Jack,Stéphanie Evrard,Vincent Bertholet,Andrew Pike,Paul Scott‐Stevens,José Remacle,Bindi Sohal	18

About Paul Scott‐Stevens

Paul Scott‐Stevens is a scholar working on Biological Psychiatry, Cellular and Molecular Neuroscience and Software, having authored 14 papers that have together received 446 indexed citations. Recurring topics across this work include Neuroscience and Neuropharmacology Research (5 papers), Protein Degradation and Inhibitors (5 papers) and Ubiquitin and proteasome pathways (4 papers). The work is most often cited by research in Physiology (65 citations), Biological Psychiatry (21 citations) and Molecular Biology (299 citations). Paul Scott‐Stevens has collaborated with scholars based in United Kingdom, United States and China. Frequent co-authors include Gillian F. Watt, Lu Gaohua, John Atack, Bindi Sohal, Philip Worboys, Jill Richardson, Odile Dewit, Zahid Ali, Louise K. Hosking and Simon McHugh. Their work appears in journals such as Angewandte Chemie International Edition, PLoS ONE and Journal of Medicinal Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact